隐匿耐药突变导致耐多药结核病误诊
研究结合全基因组测序与单菌落表型分析,追踪一例感染长达9年的耐多药结核菌株。快速检测与基因组预测工具因罕见的利福平和异烟肼耐药突变而呈假阴性,尽管全基因组测序辅助了个体化治疗,患者仍进展为广泛耐药结核病。
要点
- 罕见耐药突变可导致快速表型和基因型检测假阴性。
- 全基因组测序联合单菌落表型分析可揭示隐匿耐药。
- 新诊断方法需与恰当治疗方案联用以防耐药恶化。
核心结论
- 罕见的利福平和异烟肼耐药突变可致快速检测及基因组预测工具假阴性,进而误诊耐多药结核病。
研究设计与样本
- 结合全基因组测序与单菌落表型分析,追踪一例感染9年的耐多药结核菌株。
主要发现
- 快速检测和基因组预测工具未能识别该耐多药菌株,假阴性由不常见的利福平和异烟肼耐药突变引起。
- 全基因组测序数据辅助了个体化治疗,但患者仍发展为广泛耐药结核病。
临床怎么用
- 对快速检测或基因组预测阴性的疑似耐多药结核病例,应考虑罕见耐药突变的可能。
- 新诊断方法应与恰当治疗方案联合使用,以降低耐药进展风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Understanding why some multidrug-resistant tuberculosis cases are not detected by rapid phenotypic and genotypic routine clinical tests is essential to improve diagnostic assays and advance toward personalized tuberculosis treatment. Here, we combine whole-genome sequencing with single-colony phenotyping to identify a multidrug-resistant strain that had infected a patient for 9 years. Our investigation revealed the failure of rapid testing and genome-based prediction tools to identify the multidrug-resistant strain. The false-negative findings were caused by uncommon rifampicin and isoniazid resistance mutations. Although whole-genome sequencing data helped to personalize treatment, the patient developed extensively drug-resistant tuberculosis, highlighting the importance of coupling new diagnostic methods with appropriate treatment regimens.
引用
- Cancino-Muñoz I, Moreno-Molina M, Furió V, et al. Cryptic Resistance Mutations Associated With Misdiagnoses of Multidrug-Resistant Tuberculosis. J Infect Dis. 2019. PMID: 30875421. doi:10.1093/infdis/jiz104
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。